Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1

1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959
Hauptverfasser: Sachidanandam, Kamakshi, Hutchinson, Jim R, Elgebaly, Mostafa M, Mezzetti, Erin M, Dorrance, Anne M, Motamed, Kouros, Ergul, Adviye
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R959
container_issue 4
container_start_page R952
container_title American journal of physiology. Regulatory, integrative and comparative physiology
container_volume 296
creator Sachidanandam, Kamakshi
Hutchinson, Jim R
Elgebaly, Mostafa M
Mezzetti, Erin M
Dorrance, Anne M
Motamed, Kouros
Ergul, Adviye
description 1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California Submitted 26 June 2008 ; accepted in final form 23 January 2009 Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes. vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912
doi_str_mv 10.1152/ajpregu.90537.2008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_229747702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67077997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</originalsourceid><addsrcrecordid>eNpdkV-L1DAUxYso7uzqF_BBgg--dbxJ2qbxQVgWXYUFQdbnkDa3bcY2GZN2pN_ezM6w_nkKyfndwz05WfaKwpbSkr3Tu33AftlKKLnYMoD6SbZJAstpIeFptgFe8byiVF5klzHuAKDgBX-eXVBJRVVL2GTudlxbnGxLWu_m4EeSPA_o5kjSY_AHHdtl1IEEnLzB0bqeaGeIdW1AHdGQ2TtMV3K_7pEwYqxucMb4niT2R1IJOuPn4Tia0xfZs06PEV-ez6vs-6eP9zef87uvt19uru_ytuR0zrXodNExKbquFdCZpipqUbFOADayMbQuUINkpmpE03BsoatNaaDohKgBuOZX2YeT735pJjRtChT0qPbBTjqsymur_lWcHVTvD4pVsq6AJoO3Z4Pgfy4YZzXZ2OI4aod-iaoSIISUIoFv_gN3fgkuhVMsBSiEAJYgdoLSj8YYsHvchII6dqnOXaqHLtWxyzT0-u8Mf0bO5SUgPwGD7YdfNqDaD2u0fvT9-mjIZKUK9U2WjP8GqEqvjA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229747702</pqid></control><display><type>article</type><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</creator><creatorcontrib>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</creatorcontrib><description>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California Submitted 26 June 2008 ; accepted in final form 23 January 2009 Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes. vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</description><identifier>ISSN: 0363-6119</identifier><identifier>EISSN: 1522-1490</identifier><identifier>DOI: 10.1152/ajpregu.90537.2008</identifier><identifier>PMID: 19176890</identifier><identifier>CODEN: AJPRDO</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Collagen - metabolism ; Diabetes ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - physiopathology ; Disease Models, Animal ; Endocrinology ; Endothelin-1 - metabolism ; Glucose ; Hyperplasia ; Hypoglycemic Agents - pharmacology ; Male ; Matrix Metalloproteinase 13 - metabolism ; Mesenteric Arteries - drug effects ; Mesenteric Arteries - metabolism ; Mesenteric Arteries - pathology ; Mesenteric Arteries - physiopathology ; Metabolism ; Metformin - pharmacology ; Microvessels - drug effects ; Microvessels - metabolism ; Microvessels - physiopathology ; Proteins ; Rats ; Rats, Wistar ; Receptor, Endothelin A - metabolism ; Receptor, Endothelin B - metabolism ; Receptors and Signaling Pathways ; Rodents ; Vasoconstriction - drug effects ; Veins &amp; arteries</subject><ispartof>American journal of physiology. Regulatory, integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959</ispartof><rights>Copyright American Physiological Society Apr 2009</rights><rights>Copyright © 2009, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</citedby><cites>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3037,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19176890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sachidanandam, Kamakshi</creatorcontrib><creatorcontrib>Hutchinson, Jim R</creatorcontrib><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Dorrance, Anne M</creatorcontrib><creatorcontrib>Motamed, Kouros</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><title>American journal of physiology. Regulatory, integrative and comparative physiology</title><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><description>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California Submitted 26 June 2008 ; accepted in final form 23 January 2009 Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes. vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</description><subject>Animals</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Collagen - metabolism</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Endocrinology</subject><subject>Endothelin-1 - metabolism</subject><subject>Glucose</subject><subject>Hyperplasia</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Male</subject><subject>Matrix Metalloproteinase 13 - metabolism</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Mesenteric Arteries - metabolism</subject><subject>Mesenteric Arteries - pathology</subject><subject>Mesenteric Arteries - physiopathology</subject><subject>Metabolism</subject><subject>Metformin - pharmacology</subject><subject>Microvessels - drug effects</subject><subject>Microvessels - metabolism</subject><subject>Microvessels - physiopathology</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Endothelin A - metabolism</subject><subject>Receptor, Endothelin B - metabolism</subject><subject>Receptors and Signaling Pathways</subject><subject>Rodents</subject><subject>Vasoconstriction - drug effects</subject><subject>Veins &amp; arteries</subject><issn>0363-6119</issn><issn>1522-1490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV-L1DAUxYso7uzqF_BBgg--dbxJ2qbxQVgWXYUFQdbnkDa3bcY2GZN2pN_ezM6w_nkKyfndwz05WfaKwpbSkr3Tu33AftlKKLnYMoD6SbZJAstpIeFptgFe8byiVF5klzHuAKDgBX-eXVBJRVVL2GTudlxbnGxLWu_m4EeSPA_o5kjSY_AHHdtl1IEEnLzB0bqeaGeIdW1AHdGQ2TtMV3K_7pEwYqxucMb4niT2R1IJOuPn4Tia0xfZs06PEV-ez6vs-6eP9zef87uvt19uru_ytuR0zrXodNExKbquFdCZpipqUbFOADayMbQuUINkpmpE03BsoatNaaDohKgBuOZX2YeT735pJjRtChT0qPbBTjqsymur_lWcHVTvD4pVsq6AJoO3Z4Pgfy4YZzXZ2OI4aod-iaoSIISUIoFv_gN3fgkuhVMsBSiEAJYgdoLSj8YYsHvchII6dqnOXaqHLtWxyzT0-u8Mf0bO5SUgPwGD7YdfNqDaD2u0fvT9-mjIZKUK9U2WjP8GqEqvjA</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Sachidanandam, Kamakshi</creator><creator>Hutchinson, Jim R</creator><creator>Elgebaly, Mostafa M</creator><creator>Mezzetti, Erin M</creator><creator>Dorrance, Anne M</creator><creator>Motamed, Kouros</creator><creator>Ergul, Adviye</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090401</creationdate><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><author>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Collagen - metabolism</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Endocrinology</topic><topic>Endothelin-1 - metabolism</topic><topic>Glucose</topic><topic>Hyperplasia</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Male</topic><topic>Matrix Metalloproteinase 13 - metabolism</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Mesenteric Arteries - metabolism</topic><topic>Mesenteric Arteries - pathology</topic><topic>Mesenteric Arteries - physiopathology</topic><topic>Metabolism</topic><topic>Metformin - pharmacology</topic><topic>Microvessels - drug effects</topic><topic>Microvessels - metabolism</topic><topic>Microvessels - physiopathology</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Endothelin A - metabolism</topic><topic>Receptor, Endothelin B - metabolism</topic><topic>Receptors and Signaling Pathways</topic><topic>Rodents</topic><topic>Vasoconstriction - drug effects</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sachidanandam, Kamakshi</creatorcontrib><creatorcontrib>Hutchinson, Jim R</creatorcontrib><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Dorrance, Anne M</creatorcontrib><creatorcontrib>Motamed, Kouros</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sachidanandam, Kamakshi</au><au>Hutchinson, Jim R</au><au>Elgebaly, Mostafa M</au><au>Mezzetti, Erin M</au><au>Dorrance, Anne M</au><au>Motamed, Kouros</au><au>Ergul, Adviye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</atitle><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>296</volume><issue>4</issue><spage>R952</spage><epage>R959</epage><pages>R952-R959</pages><issn>0363-6119</issn><eissn>1522-1490</eissn><coden>AJPRDO</coden><abstract>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California Submitted 26 June 2008 ; accepted in final form 23 January 2009 Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes. vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>19176890</pmid><doi>10.1152/ajpregu.90537.2008</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-6119
ispartof American journal of physiology. Regulatory, integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959
issn 0363-6119
1522-1490
language eng
recordid cdi_proquest_journals_229747702
source MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Blood Glucose - drug effects
Blood Glucose - metabolism
Collagen - metabolism
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - physiopathology
Disease Models, Animal
Endocrinology
Endothelin-1 - metabolism
Glucose
Hyperplasia
Hypoglycemic Agents - pharmacology
Male
Matrix Metalloproteinase 13 - metabolism
Mesenteric Arteries - drug effects
Mesenteric Arteries - metabolism
Mesenteric Arteries - pathology
Mesenteric Arteries - physiopathology
Metabolism
Metformin - pharmacology
Microvessels - drug effects
Microvessels - metabolism
Microvessels - physiopathology
Proteins
Rats
Rats, Wistar
Receptor, Endothelin A - metabolism
Receptor, Endothelin B - metabolism
Receptors and Signaling Pathways
Rodents
Vasoconstriction - drug effects
Veins & arteries
title Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A22%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycemic%20control%20prevents%20microvascular%20remodeling%20and%20increased%20tone%20in%20Type%202%20diabetes:%20link%20to%20endothelin-1&rft.jtitle=American%20journal%20of%20physiology.%20Regulatory,%20integrative%20and%20comparative%20physiology&rft.au=Sachidanandam,%20Kamakshi&rft.date=2009-04-01&rft.volume=296&rft.issue=4&rft.spage=R952&rft.epage=R959&rft.pages=R952-R959&rft.issn=0363-6119&rft.eissn=1522-1490&rft.coden=AJPRDO&rft_id=info:doi/10.1152/ajpregu.90537.2008&rft_dat=%3Cproquest_pubme%3E67077997%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229747702&rft_id=info:pmid/19176890&rfr_iscdi=true